The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation
Alterations of the gut microbiota may cause dysregulated mucosal immune responses leading to the onset of inflammatory bowel diseases (IBD) in genetically susceptible hosts. Restoring immune homeostasis through the normalization of the gut microbiota is now considered a valuable therapeutic approach...
Main Authors: | Chiara Amoroso, Federica Perillo, Francesco Strati, Massimo Fantini, Flavio Caprioli, Federica Facciotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1234 |
Similar Items
-
Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition
by: Claudia Burrello, et al.
Published: (2019-05-01) -
Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases
by: Maria Barra, et al.
Published: (2020-03-01) -
Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
by: Nagarakanti S, et al.
Published: (2023-05-01) -
A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent <i>Clostridioides difficile</i> Infection
by: Yifan Wang, et al.
Published: (2024-05-01) -
Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection
by: Kanika Sehgal, et al.
Published: (2024-05-01)